A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention

OBJECTIVE: Studies examining the effects of tirofiban combined with other conventional drugs for treating patients with acute coronary syndrome (ACS) are lacking. Thus, in this study, we conducted a meta-analysis investigating both the safety and efficacy of intracoronary (IC) administration of tiro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Qian, Zhang, Long Dan, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Cardiology 2020
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803802/
https://www.ncbi.nlm.nih.gov/pubmed/33382055
http://dx.doi.org/10.14744/AnatolJCardiol.2020.99469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803802/
https://www.ncbi.nlm.nih.gov/pubmed/33382055
http://dx.doi.org/10.14744/AnatolJCardiol.2020.99469

Ejemplares similares